The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. LifeTech Scientific's Revenue for the
six
months ended in Dec. 2025 was $98.4 Mil. LifeTech Scientific's average Accounts Receivable for the
six
months ended in Dec. 2025 was $25.8 Mil.
Hence, LifeTech Scientific's Receivables Turnover for the
six
months ended in Dec. 2025 was 3.82.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
LifeTech Scientific Receivables Turnover Related Terms
LifeTech Scientific Receivables Turnover Historical Data
* Premium members only.
The historical data trend for LifeTech Scientific's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LFTSF vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, LifeTech Scientific's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeTech Scientific Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where LifeTech Scientific's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeTech Scientific (LFTSF) has a Receivables Turnover of 3.82 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on LifeTech Scientific and its competitors. According to the industry distribution chart, LifeTech Scientific ranks #163 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 20%.
Is LifeTech Scientific's Receivables Turnover too high?
LifeTech Scientific's current Receivables Turnover is 3.82. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. LifeTech Scientific's value of 3.82 is 30.7% below this industry median. Based on the distribution chart, LifeTech Scientific ranks #163 out of 813 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, LifeTech Scientific has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, LifeTech Scientific ranks #163 out of 813 companies for Receivables Turnover. This places LifeTech Scientific in the top 20% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.51. LifeTech Scientific's value of 3.82 is 30.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeTech Scientific's current Receivables Turnover of 3.82 is 30.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on LifeTech Scientific and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeTech Scientific's current Receivables Turnover is 3.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (LFTSF) has a current Receivables Turnover of 3.82. The stock's GF Value™ is $0.35, compared to a current price of $0.23 — trading 33.3% below its estimated fair value. The current Receivables Turnover is 3.82 and 30.7% below the Medical Devices & Instruments industry median of 5.51. LifeTech Scientific's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For LifeTech Scientific (LFTSF), the current Receivables Turnover is 3.82 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeTech Scientific (LFTSF) Overvalued in 2026?
Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued.
The current stock price of $0.23 is trading 33.3% below its estimated GF Value™ of $0.35.
Key valuation signals for LFTSF:
Receivables Turnover: 3.82
GF Value™: $0.35 vs. price of $0.23 (33.3% below fair value)
Industry Position: 30.7% below the Medical Devices & Instruments median (#163 of 813)
No single metric tells the full story. See the LFTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
95GF Score
Get the complete analysis for LFTSF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFTSF has been successfully added to your 
